Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

| More on:
A young man sits at his desk working on his laptop with a big smile on his face.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Many of Australia's top brokers have been busy adjusting their financial models and recommendations again. This has led to the release of a number of broker notes this week.

Three ASX shares that brokers have named as buys this week are listed below. Here's why their analysts are feeling bullish on them right now:

CSL Ltd (ASX: CSL)

According to a note out of Macquarie, its analysts have retained their outperform rating on this biotechnology company's shares with a reduced price target of $295.90. Macquarie notes that CSL delivered a full year result that was short of expectations in FY 2025 due to the underperformance of the key CSL Behring business. However, it believes the selloff has been an overreaction. And even after reducing its earnings estimates, it believes this leaves the company's shares trading on an undemanding valuation (trading at P/E ~20x with ~10% EPS growth). As a result, it thinks investors should be buying the dip. The CSL share price ended the day at $220.74.

HMC Capital Ltd (ASX: HMC)

A note out of Morgans reveals that its analysts have upgraded this investment company's shares to a buy rating with a $4.20 price target. The broker made the move on valuation grounds, highlighting that recent share price weakness has dragged its shares below book value. It estimates that the current share price was implying that HMC Capital was ex-growth, which it does not believe to be the case. It also thinks that settling the Healthscope negotiations, getting its data centre investments back on track with a material contract, and the de-gearing of the Energy Transition Fund would restore investor faith and help re-rate its shares. The good news is that it thinks this is achievable over the next 12 months. The HMC Capital was fetching $3.85 at Wednesday's close.

Hub24 Ltd (ASX: HUB)

Analysts at Bell Potter have retained their buy rating on this investment platform provider's shares with an improved price target of $125.00. According to the note, the broker was pleased with another strong performance from Hub24 in FY 2025. It expects this trend to continue and believes that Hub24 is on-track to meet its FY 2026 Platform FUA target of $123 billion to $135 billion. This is expected to underpin earnings per share growth of 28% this year. The broker then sees a clear pathway to $148 billion to $162 billion in FY 2027 based on the strong acceleration in net flows from new licensee and adviser relationships. The Hub24 share price ended the week at $104.84.

Motley Fool contributor James Mickleboro has positions in CSL. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, HMC Capital, Hub24, and Macquarie Group. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended CSL, HMC Capital, and Hub24. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Broker looking at the share price.
Broker Notes

Broker ratings on 6 ASX shares about to join the ASX 200

These 6 companies will enter the ASX 200 in the December quarter rebalance. Should you buy them?

Read more »

A happy elderly woman smiles and cheers as she looks at good investment news on her laptop.
Broker Notes

Macquarie forecasts this $3.4 billon ASX healthcare share is set surge 33%

Macquarie tips material outperformance from this ASX healthcare share in 2026.

Read more »

Man looking at digital holograms of graphs, charts, and data.
Broker Notes

3 reasons this ASX 300 tech stock is forecast to leap 83% in 2026

A leading broker expects some outsized returns from this ASX 300 tech share. Let’s see why.

Read more »

gold share price represented by speeding golden bullet
Broker Notes

Why this surging ASX All Ords gold stock is tipped to rocket another 233%

A leading broker expects outsized gains from this ASX All Ords gold stock. But not without risk.

Read more »

A blockchain investor sits at his desk with a laptop computer open and a phone checking information from a booklet in a home office setting.
Broker Notes

3 buy-rated ASX 300 shares at 52-week lows

They've fallen far over the past 12 months but have buy ratings from the experts.

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Broker Notes

Bell Potter names more of the best ASX 200 shares to buy in December

These are best buys according to the broker. Here's what it is saying about them.

Read more »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company
Broker Notes

These ASX 200 shares could rise 30% to 40% in 2026

Looking for big returns? Analysts think these shares could beat the market.

Read more »

Ecstatic woman looking at her phone outside with her fist pumped.
Broker Notes

Analysts name 3 ASX shares to buy this week

Analysts have good things to say about these shares.

Read more »